Stem cell induced inflammatory hypertrophy of the cauda equina

Area of Science:

• Neurology
• Regenerative Medicine
• Medical Complications

Background:

• Stem cell therapy is increasingly sought internationally for neurologic conditions, often outpacing safety and efficacy research.
• Intrathecal administration of stem cells is a common route for neurologic applications.
• Stem cell tourism presents unique challenges for patient safety and clinical management.

Observation:

• A patient developed symptomatic inflammatory cauda equina nerve root hypertrophy.
• This complication arose following intrathecal stem cell infusion.
• The presentation highlights a rare but serious adverse event associated with stem cell therapy.

Findings:

• Intrathecal stem cell infusion can lead to inflammatory nerve root hypertrophy.
• This condition represents a significant, albeit uncommon, complication of stem cell therapy.
• The case underscores the need for vigilance regarding potential adverse events.

Implications:

• Clinicians must be aware of rare complications associated with stem cell therapy, particularly intrathecal administration.
• Further research is crucial to understand the long-term safety and efficacy of stem cell treatments.
• Patient education regarding the risks of stem cell tourism is essential for informed decision-making.